Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways

被引:115
|
作者
Taylor, C [1 ]
Fricker, AD [1 ]
Devi, LA [1 ]
Gomes, N [1 ]
机构
[1] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA
关键词
anxiety; depression; neurogenesis; SSRI; CRH; cortisol;
D O I
10.1016/j.cellsig.2004.12.007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Antidepressants are commonly used in the treatment of anxiety and depression, medical conditions that affect similar to17-20% of the population. The clinical effects of antidepressants take several weeks to manifest, suggesting that these drugs induce adaptive changes in brain structures affected by anxiety and depression. In order to develop shorter-acting and more effective drugs for the treatment of anxiety and depression, it is important to understand how antidepressants bring about their beneficial effects. Recent reports suggest that antidepressants can induce neurogenesis in the adult brain, although the mechanisms involved are not clearly understood. In this review, we describe the different neurotransmitter systems that are affected by anxiety and depression and how they are modulated by antidepressant treatment with a focus on signaling molecules and pathways that are activated during neurotransmitter receptor induced neurogenesis. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:549 / 557
页数:9
相关论文
共 50 条
  • [41] Regulation Mechanisms and Signaling Pathways of Autophagy
    He, Congcong
    Klionsky, Daniel J.
    ANNUAL REVIEW OF GENETICS, 2009, 43 : 67 - 93
  • [42] Signaling pathways and defense mechanisms of ferroptosis
    Liu, Jiao
    Kang, Rui
    Tang, Daolin
    FEBS JOURNAL, 2022, 289 (22) : 7038 - 7050
  • [43] Potential Mechanisms of Action of Dietary Phytochemicals for Cancer Prevention by Targeting Cellular Signaling Transduction Pathways
    Chen, Hongyu
    Liu, Rui Hai
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, 66 (13) : 3260 - 3276
  • [44] IMPLICATIONS OF CLINICAL SPECTRUM FOR MECHANISMS OF ACTION - ECT AND ANTIDEPRESSANTS RECONSIDERED
    LICHTENBERG, P
    LERER, B
    CONVULSIVE THERAPY, 1989, 5 (03): : 216 - 226
  • [45] THE NEWER ANTIDEPRESSANTS - STRUCTURES, PHARMACOKINETICS, PHARMACODYNAMICS, AND PROPOSED MECHANISMS OF ACTION
    RICHELSON, E
    PSYCHOPHARMACOLOGY BULLETIN, 1984, 20 (02) : 213 - 223
  • [46] Overview of Antagonists Used for Determining the Mechanisms of Action Employed by Potential Vasodilators with Their Suggested Signaling Pathways
    Loh, Yean Chun
    Tan, Chu Shan
    Ch'ng, Yung Sing
    Ahmad, Mariam
    Asmawi, Mohd Zaini
    Yam, Mun Fei
    MOLECULES, 2016, 21 (04):
  • [47] ADRENERGIC MECHANISMS IN CENTRAL ACTION OF TRICYCLIC ANTIDEPRESSANTS AND SUBSTITUTED PHENOTHIAZINES
    SULSER, F
    DINGELL, JV
    AGRESSOLOGIE, 1968, 9 (02): : 281 - &
  • [48] Antidepressants with different action mechanisms in the treatment of chronic daily headache
    Amelin, A. V.
    Tarasova, S. V.
    Ignatov, Yu. D.
    Skoromets, A. A.
    Myatleva, M. I.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2007, 107 (09) : 38 - 44
  • [49] DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
    Wang, Shan
    Shi, Xiangde
    Li, Hao
    Pang, Pei
    Pei, Lei
    Shen, Huiyong
    Lu, Youming
    MOLECULAR NEUROBIOLOGY, 2017, 54 (06) : 4716 - 4722
  • [50] DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
    Shan Wang
    Xiangde Shi
    Hao Li
    Pei Pang
    Lei Pei
    Huiyong Shen
    Youming Lu
    Molecular Neurobiology, 2017, 54 : 4716 - 4722